BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21055173)

  • 21. Precursor B- or T-lymphoblastic lymphoma presenting with cutaneous involvement: a series of 13 cases including 7 cases of cutaneous T-lymphoblastic lymphoma.
    Lee WJ; Moon HR; Won CH; Chang SE; Choi JH; Moon KC; Lee MW
    J Am Acad Dermatol; 2014 Feb; 70(2):318-25. PubMed ID: 24314877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinicopathologic features of lymphoplasmacytic lymphoma].
    Liu EB; Zhang PH; Li ZQ; Sun Q; Yang QY; Fang LH; Sun FJ; Qiu LG
    Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):308-12. PubMed ID: 20654153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
    Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
    Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma.
    Li S; Juco J; Mann KP; Holden JT
    Am J Clin Pathol; 2004 Feb; 121(2):268-74. PubMed ID: 14983942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T-lymphoblastic lymphoma/leukemia without clonal
    Wang J; Jiang S; Zhao Q; Wei X; Li W
    Transl Cancer Res; 2021 Mar; 10(3):1603-1608. PubMed ID: 35116486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression and clinical significance of Mcl-1 in T-cell non-Hodgkin's lymphoma].
    Lin XB; Jiang WQ; Zhong XY; Luo RZ
    Ai Zheng; 2007 Apr; 26(4):435-9. PubMed ID: 17430669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiating lymphoblastic lymphoma and Ewing's sarcoma: lymphocyte markers and gene rearrangement.
    Ozdemirli M; Fanburg-Smith JC; Hartmann DP; Azumi N; Miettinen M
    Mod Pathol; 2001 Nov; 14(11):1175-82. PubMed ID: 11706081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinicopathologic features of peripheral T-cell lymphoma, unspecified with follicular pattern].
    Wang W; Ji FS; Chen HS; Zhang NX; Zhang SY; Zhang L; Liu EB; Yang QY; Fang LH; Sun FJ
    Zhonghua Bing Li Xue Za Zhi; 2009 Apr; 38(4):248-52. PubMed ID: 19575896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A clinicopathological study of 96 cases of lymphoblastic lymphoma].
    Pan Y; Liu WP; Li JF; Zhang WY; Li FY; Lu XX; Li D; Li GD
    Zhonghua Xue Ye Xue Za Zhi; 2005 Apr; 26(4):218-22. PubMed ID: 15949264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Value of CD, MPO, Ki-67 and C-MYC Positive Rate in the Pathological Tissues and C-MYC Gene of Patients with T-LBL/ALL for Predicting Prognosis].
    Wu Y; Tang HY; Ding YY; Pan XQ; Tan CM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb; 26(1):110-115. PubMed ID: 29397827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical outcome of childhood lymphoblastic lymphoma in Shanghai China 2001-2010.
    Gao YJ; Pan C; Tang JY; Lu FJ; Chen J; Xue HL; Zhai XW; Li J; Ye QD; Zhou M; Wang HS; Miao H; Qian XW; Xu Z; Meng JH
    Pediatr Blood Cancer; 2014 Apr; 61(4):659-63. PubMed ID: 24243691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of miRNA-17 and miRNA-19 is associated with unfavorable prognosis in patients with T-cell lymphoblastic lymphoma.
    Xi Y; Li J; Zhang P; Bai W; Gao N; Bai W; Zhang Y; Wu Y; Ning Y
    Exp Mol Pathol; 2015 Oct; 99(2):297-302. PubMed ID: 26231295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of myeloid antigen expression in precursor T lymphoblastic lymphoma.
    Cai Y; Sun XF; Yan SL; Zhen ZJ; Xia Y; Ling JY
    Chin J Cancer; 2010 Mar; 29(3):312-6. PubMed ID: 20193116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Precursor B-Lymphoblastic lymphoma presenting as a solitary bone tumor and mimicking Ewing's sarcoma: a report of four cases and review of the literature.
    Ozdemirli M; Fanburg-Smith JC; Hartmann DP; Shad AT; Lage JM; Magrath IT; Azumi N; Harris NL; Cossman J; Jaffe ES
    Am J Surg Pathol; 1998 Jul; 22(7):795-804. PubMed ID: 9669342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinicopathologic features of intestinal natural killer/T-cell lymphoma].
    Zhou J; Yu B; He Y; Wu B; Zhang XH; Zhou XJ; Shi QL
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):243-7. PubMed ID: 23928531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T cell receptor genotyping and HOXA/TLX1 expression define three T lymphoblastic lymphoma subsets which might affect clinical outcome.
    Baleydier F; Decouvelaere AV; Bergeron J; Gaulard P; Canioni D; Bertrand Y; Lepretre S; Petit B; Dombret H; Beldjord K; Molina T; Asnafi V; Macintyre E
    Clin Cancer Res; 2008 Feb; 14(3):692-700. PubMed ID: 18245528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BCL-1 (PRAD-1/cyclin D-1) overexpression distinguishes the blastoid variant of mantle cell lymphoma from B-lineage lymphoblastic lymphoma.
    Soslow RA; Zukerberg LR; Harris NL; Warnke RA
    Mod Pathol; 1997 Aug; 10(8):810-7. PubMed ID: 9267824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NOTCH1 intracellular domain immunohistochemistry as a diagnostic tool to distinguish T-lymphoblastic lymphoma from thymoma.
    Jegalian AG; Bodo J; Hsi ED
    Am J Surg Pathol; 2015 Apr; 39(4):565-72. PubMed ID: 25517959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia.
    Akashi K; Mizuno S; Harada M; Kimura N; Kinjyo M; Shibuya T; Shimoda K; Takeshita M; Okamura S; Matsumoto I
    Exp Hematol; 1993 Jun; 21(6):743-8. PubMed ID: 7684698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Primary ovarian precursor T-lymphoblastic lymphoma: report of a case].
    Liu XY; Zhong SJ; Mi XJ; Chen ZQ; Huang YX; Chen YY
    Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):850-1. PubMed ID: 23324239
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.